Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732537 · ClinicalTrials.gov registry record · Phase 4
Inhaled Nitric Oxide by Oxygen Hood in Neonates
A Phase 4 study of Respiratory Failure and Infant, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT00732537: Completed Phase 4 study of Respiratory Failure and Infant, sponsored by University of Alabama at Birmingham.
NCT00732537 is a Phase 4 study of Respiratory Failure and Infant that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 8 participants, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00732537, a Phase 4 study of Respiratory Failure and Infant, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near-term infants who have poor oxygenation but who are not yet mechanically ventilated.
Conditions Studied
Interventions
- DRUG inhaled Nitric Oxide
- DRUG Oxygen (>90% by hood) - standard therapy
Study Locations (1)
Alabama
- Regional Neonatal ICU, University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 1999-03 |
| Est. Completion | 2005-06 |
| Phase | Phase 4 |
What the finished NCT00732537 record still lists
NCT00732537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 4,524-participant average among 40 other Respiratory Failure trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which inhaled Nitric Oxide is the first listed.
NCT00732537 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00732537 about?
NCT00732537 is a clinical study titled "Inhaled Nitric Oxide by Oxygen Hood in Neonates". Inhaled nitric oxide (iNO) improves oxygenation in term infants with respiratory failure. However, iNO has been primarily used in infants receiving mechanical ventilation. This study is a pilot study to determine if iNO given into an oxygen hood is effective in improving oxygenation in term and near...
What is the current status of trial NCT00732537?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 1999-03. Estimated completion is 2005-06.
What conditions does trial NCT00732537 study?
This clinical trial studies the following conditions: Respiratory Failure, Infant, Persistent Fetal Circulation.
What interventions are being tested in trial NCT00732537?
The interventions under investigation include: inhaled Nitric Oxide (DRUG), Oxygen (>90% by hood) - standard therapy (DRUG).
Who is sponsoring clinical trial NCT00732537?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00732537 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00732537's enrollment target sits among peer trials
8 40th of 40 higher than 1 of 40 other Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
ACTIVE NOT RECRUITING · Phase 4
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia